INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Dawson Geophysical Company (NASDAQ: DWSN) (the "Company") today reported unaudited financial results for its third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback